ATOS · CIK 0001488039 · operating
ATOSSA THERAPEUTICS, INC. (ATOS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $37 million, ATOSSA THERAPEUTICS, INC. is a micro-cap company. The stock currently trades at $4.55, up 2.71% today, with a 52-week range of $3.76–$19.35.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.20 | $-0.20 | +16.7% | |
| 2023 | $-0.24 | $-0.24 | -14.3% | |
| 2022 | — | $-0.21 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-25 | 0000950170-25-044099 | SEC ↗ |
| 2023-12-31 | 2024-04-01 | 0000950170-24-039306 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0001437749-23-007531 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001437749-22-004614 | SEC ↗ |
| 2020-12-31 | 2021-03-31 | 0001437749-21-007756 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001437749-20-006155 | SEC ↗ |
| 2018-12-31 | 2019-03-28 | 0001437749-19-005927 | SEC ↗ |
| 2017-12-31 | 2018-03-08 | 0001615774-18-001693 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001615774-17-001088 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001144204-16-091380 | SEC ↗ |
| 2014-12-31 | 2015-03-30 | 0001144204-15-019344 | SEC ↗ |
| 2013-12-31 | 2014-03-27 | 0001144204-14-018247 | SEC ↗ |
| 2012-12-31 | 2013-03-28 | 0001144204-13-018024 | SEC ↗ |